Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow

This publication has 27 references indexed in Scilit:

• The effects of milrinone (Win 47203) on the coronary blood flow and oxygen consumption of the dog heart-lung preparation
  American Heart Journal, 1986
• Effects of amrinone on myocardial energetics in severe congestive heart failure
  The American Journal of Cardiology, 1985
• Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
  Circulation, 1985
• Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure
  Journal of the American College of Cardiology, 1985
• Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure
  American Heart Journal, 1984
• Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart Failure
  New England Journal of Medicine, 1983
• The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy
  American Heart Journal, 1983
• Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
  Circulation, 1980
• The metabolic demand and oxygen supply of the heart: Physiologic and clinical considerations
  The American Journal of Cardiology, 1979
• Control of myocardial oxygen consumption
  The American Journal of Cardiology, 1971